VAV1 and neoplasm: Thus, the transcriptional silencing of the VAV1 gene in some clinical subtypes of T cell acute lymphoblastic leukemia has been shown to be essential to eliminate the tumor suppressor activity of Vav1 against the Notch1 pathway.